This edition incorporates a new trend in drug discovery, namely the consideration of pharmacokinetics and ADME properties of drugs (absorption, distribution, metabolism, excretion) early in the process. As prospective new drugs are tested in more complex systems (with concomitantly more complex dependent variable values), the trend in screening is to test fewer compounds of higher (druglike) quality. Finally, this edition also hopefully fills a previous void ...
